Vai al contenuto principale della pagina

Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy [[electronic resource]]



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Titolo: Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy [[electronic resource]] Visualizza cluster
Pubblicazione: Lyon, France, : International Agency for Research on Cancer
Geneva, : Distributed by WHO Press, 2007
Descrizione fisica: 1 online resource (543 p.)
Soggetto topico: Progestational hormones - Carcinogenicity
Progestational hormones - Side effects
Catechol estrogens - Carcinogenicity
Estrogen - Carcinogenicity
Catechol estrogens - Side effects
Estrogen - Side effects
Contraception - Complications
Menopause - Hormone therapy - Complications
Chemical carcinogenesis
Cancer - Risk factors
Women - Diseases - Risk factors
Oral contraceptives - Carcinogenicity
Soggetto genere / forma: Electronic books.
Note generali: At head of title: World Health Organization, International Agency for Research on Cancer.
"This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 7-14 June 2005."
Nota di bibliografia: Includes bibliographical references and cumulative index.
Nota di contenuto: Preliminaries; CONTENTS; PREAMBLE; Combined Estrogen-Progestogen Contraceptives; Combined Estrogen-Progestogen Menopausal Therapy; ANNEXES; CUMULATIVE INDEX TO THE MONOGRAPHS SERIES;
Sommario/riassunto: Oral contraceptives for family planning worldwide have revolutionized the reproductive lives of millions of women since their introduction in the 1960's. Later on, a variety of side-effects including cardiovascular diseases was recognized. In response to these concerns, new generations of combined oral contraceptives were developed that featured lower dose of estrogen and newer, more potent progestogens. The effectiveness and ease of use of combined hormonal contraceptives suggest that they will continue to be used to a significant extent in the future. This ninety-first volume of IARC Monographs
Titolo autorizzato: Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy  Visualizza cluster
ISBN: 1-281-82961-7
9786611829612
92-4-068321-6
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910453419503321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Serie: IARC monographs on the evaluation of carcinogenic risks to humans ; ; v. 91.